BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petramala L, Letizia C. Response to: Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan). Eur Heart J Cardiovasc Pharmacother 2020;6:252. [PMID: 32352509 DOI: 10.1093/ehjcvp/pvaa035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Acanfora D, Ciccone MM, Scicchitano P, Acanfora C, Casucci G. Sacubitril/valsartan in COVID-19 patients: the need for trials. Eur Heart J Cardiovasc Pharmacother 2020;6:253-4. [PMID: 32369103 DOI: 10.1093/ehjcvp/pvaa044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]